Search Results - "Morais de Azevedo, Wellington"
-
1
Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
Published in The New England journal of medicine (25-01-2007)“…This randomized, double-blind trial of prophylaxis to prevent invasive fungal infections was conducted in 600 patients with severe graft-versus-host disease…”
Get full text
Journal Article -
2
Minimal Residual Disease in Acute Myeloid Leukemia (AML) and Hematopoietic Stem Cell Transplantation (HSCT) - A Retrospective Study
Published in Blood (18-11-2011)“…Abstract 4469 Minimal Residual Disease (MRD) is an important criterion to define risk of relapse in Acute Leukemia (AL). The most powerful methods for MRD…”
Get full text
Journal Article -
3
The Development of Hematopoietic Stem Cell Transplantation (HSCT) in Patients with Chronic Myeloid Leukemia (CML), in First Chronic Phase (CP), with HLA Identical Siblings Donors at the Bone Marrow Transplantation Unity–Jau, São Paulo/Brazil and Regional Cooperative Group
Published in Blood (16-11-2008)“…Since August 1996, we have perfomed 206 hematopoietic stem cell transplantations (HSCT) in patients with Chronic Myeloid Leukemia (CML). The number of…”
Get full text
Journal Article -
4
The Development of Hematopoietic Stem Cell Transplantation (HSCT) in Patients with Chronic Myeloid Leukemia (CML), in First Chronic Phase (CP), with HLA Identical Siblings Donors at the Bone Marrow Transplantation Unity–Jau, São Paulo/Brazil and Regional Cooperative Group
Published in Blood (16-11-2008)“…Since August 1996, we have perfomed 206 hematopoietic stem cell transplantations (HSCT) in patients with Chronic Myeloid Leukemia (CML). The number of…”
Get full text
Journal Article -
5
Vascular endothelial growth factor (VEGF) and chronic graft-versus-host disease (cGVHD) in salivary glands of bone marrow transplant (BMT) recipients
Published in Journal of oral pathology & medicine (01-01-2004)“…Background: The purpose of this study was to compare the immunolocalization of vascular endothelial growth factor (VEGF) in salivary glands of bone marrow…”
Get full text
Journal Article